In a 60‑year‑old woman with hypothyroidism weighing 108 kg who is taking levothyroxine 200 µg six days per week and 300 µg on Sunday with a suppressed thyroid‑stimulating hormone, how should the levothyroxine dose be reduced?

Reduce levothyroxine by 12.5-25 mcg daily and recheck TSH in 4-8 weeks

This patient is overtreated with a suppressed TSH of 0.018 mIU/L, requiring immediate dose reduction to prevent cardiovascular complications (particularly atrial fibrillation) and accelerated bone loss—risks that are especially concerning in a 60-year-old postmenopausal woman. 1

Current Dosing Analysis

Her current weekly regimen equals approximately 214 mcg daily (200 mcg × 6 days + 300 mcg × 1 day = 1,500 mcg/week ÷ 7 = 214 mcg/day). This is a high dose, and at 108 kg body weight, she's receiving approximately 2.0 mcg/kg/day—well above the typical replacement dose of 1.6 mcg/kg/day 2.

Recommended Dose Adjustment

Reduce the daily dose by 12.5-25 mcg 1. Given the degree of TSH suppression, I recommend:

• Reduce to 175-187.5 mcg daily (approximately 12.5-25% reduction)
• Practical regimen: 175 mcg daily for simplicity, or alternate 175/200 mcg if using available tablet strengths
• Recheck TSH in 4-8 weeks 1, 2

Clinical Reasoning

Why This Magnitude of Reduction?

The guidelines specify increment changes of 12.5-25 mcg when adjusting doses 1. While her TSH is significantly suppressed, elderly patients (age 60+) require 20-25% less levothyroxine per kilogram than younger patients due to decreased lean body mass 1. A 25 mcg reduction represents approximately 12% of her current dose—a conservative but meaningful adjustment.

Age-Related Considerations

At 60 years old, this patient falls into the category where decreased levothyroxine requirements are expected 1, 3. Research demonstrates that patients over 60 commonly need only 100 mcg/day or less, with some requiring as little as 50 mcg/day 3. Her current dose of 214 mcg/day is disproportionately high for her age.

Risks of Overtreatment

The principal adverse consequences of overtreatment are cardiovascular and skeletal 1:

• Cardiovascular: Atrial fibrillation (elderly are particularly susceptible), increased cardiovascular mortality 1
• Skeletal: Accelerated bone loss in postmenopausal women 1
• Affective: Possible mood disturbances 1

Overtreatment occurs in approximately 20% of patients on thyroid hormone 1, making this a common and preventable problem.

Monitoring Strategy

1. Recheck TSH in 4-8 weeks after dose adjustment 1, 2
2. Target TSH: 0.4-4.12 mIU/L (normal reference range) 1
3. If TSH remains suppressed, make additional 12.5-25 mcg reductions
4. Once stable, monitor TSH every 6-12 months 1

Important Caveats

Rule Out Non-Compliance First

Before assuming true overtreatment, confirm she's actually taking the medication as prescribed. Patients on high doses (>200 mcg/day) with abnormal TSH may have compliance issues 1. However, in this case, the suppressed (not elevated) TSH confirms she's taking excessive medication.

Consider Absorption Issues

Ensure she's taking levothyroxine properly:

• 30-60 minutes before breakfast with water, or at bedtime 4 hours after last meal 1
• Avoid concurrent intake with substances that impair absorption (iron, calcium, proton pump inhibitors, fiber) 1

Weight Considerations

At 108 kg, if this represents recent weight gain, her dose may have been appropriate at a lower weight. Conversely, if she's lost significant weight, dose requirements decrease 1. Reassess ideal body weight versus actual weight when calculating optimal dosing.

Alternative Consideration

If compliance is genuinely problematic despite the suppressed TSH suggesting good adherence, weekly dosing is an option that produces similar outcomes and acceptable TSH values 1, 4. However, this is not indicated in her case given the current overtreatment.